OPRM1 and neoplasm: Although preclinical evidence indicates that μ-opioid receptor (MOR) activation might promote tumor progression in hepatocellular carcinoma (Li et al., 2019), the potential survival benefits of an opioid-free anesthetic regime in this context remain speculative and require prospective clinical validation.